Atlas Brown,Inc. Gsk PLC Transaction History

Atlas Brown,Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 13, 2021	SELL	$34.27 - $40.01 $856 - $1,000	-25 Reduced 0.43%	5,827 $208,000
Q4 2020 Jan 19, 2021	SELL	$34.07 - $39.94 $68,140 - $79,880	-2,000 Reduced 25.47%	5,852 $215,000
Q3 2020 Oct 15, 2020	BUY	$38.11 - $42.99 $74,886 - $84,475	1,965 Added 33.38%	7,852 $296,000
Q2 2020 Jul 21, 2020	BUY	$37.87 - $43.58 $222,940 - $256,555	5,887 New	5,887 $240,000
Q1 2020 Apr 16, 2020	SELL	$32.47 - $48.83 $139,101 - $209,187	-4,284 Closed	0 $0
Q4 2019 Jan 14, 2020	BUY	$42.0 - $48.25 $179,928 - $206,703	4,284 New	4,284 $201,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Atlas Brown,Inc., based on Form 13F filings with the SEC.

Stay updated on Atlas Brown,Inc. with notifications on news.